AFLURIA INFLUENZA VACCINE
Live / Allowed — Fourth extension granted (statement of use) (as of 05 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98402360
- Mark type
- Design + words
- Filed
- 12 Feb 2024
- Published for opposition
- 15 Oct 2024
- Attorney of record
- Nancy Sabarra
Goods and services
- Class 005 — Pharmaceuticals: Influenza vaccines for human use
Owner
- CSL Limited, Melbourne, AU
- CSL Limited, Melbourne, AU
Prosecution history
- 06 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2026 — SOU EXTENSION 4 GRANTED
- 05 Aug 2026 — SOU EXTENSION 4 FILED
- 05 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Apr 2026 — SOU EXTENSION 3 GRANTED
- 06 Apr 2026 — SOU EXTENSION 3 FILED
- 06 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Nov 2025 — SOU EXTENSION 2 GRANTED
- 24 Nov 2025 — SOU EXTENSION 2 FILED
- 24 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 1 GRANTED
- 16 May 2025 — SOU EXTENSION 1 FILED